HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carlo Castellani Selected Research

Pharmaceutical Preparations

4/2021Identification of Potential Leukocyte Biomarkers Related to Drug Recovery of CFTR: Clinical Applications in Cystic Fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carlo Castellani Research Topics

Disease

21Cystic Fibrosis (Mucoviscidosis)
05/2022 - 06/2005
3Lung Diseases (Lung Disease)
01/2020 - 01/2018
3Pancreatitis
01/2011 - 07/2003
2Infections
01/2020 - 02/2016
1Disease Progression
04/2021
1Macular Degeneration (Age-Related Maculopathy)
01/2021
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021
1Malnutrition (Nutritional Deficiencies)
01/2020
1Persistent Infection
01/2020
1Pancreatic Diseases (Pancreatic Disease)
10/2019
1Cysts
01/2017
1Meconium Ileus
04/2016
1Pneumothorax
02/2016
1Respiratory Insufficiency (Respiratory Failure)
02/2016
1Death (Near-Death Experience)
02/2016
1Liver Diseases (Liver Disease)
09/2009
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2006
1Chronic Pancreatitis
06/2006

Drug/Important Bio-Agent (IBA)

8Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
04/2021 - 07/2003
5TrypsinogenIBA
10/2019 - 06/2005
4ivacaftorIBA
05/2022 - 01/2019
3ChloridesIBA
01/2017 - 06/2005
2elexacaftorIBA
03/2022 - 03/2022
2Anti-Bacterial Agents (Antibiotics)IBA
09/2021 - 01/2020
2TrypsinIBA
10/2007 - 06/2006
2Kazal Pancreatic Trypsin InhibitorIBA
06/2006 - 07/2003
1tezacaftor drug combination ivacaftor elexacaftorIBA
03/2022
1tezacaftorIBA
03/2022
1ivacaftor drug combination tezacaftorIBA
03/2022
1Chloride Channels (Chloride Channel)IBA
03/2022
1Poly TIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
04/2021
1Pharmaceutical PreparationsIBA
04/2021
1afliberceptIBA
01/2021
1Bevacizumab (Avastin)FDA Link
01/2021
1EnzymesIBA
01/2020
1Expectorants (Mucolytics)IBA
01/2020
1ceftazidime drug combination avibactamIBA
11/2019
1Ceftazidime (Fortum)FDA LinkGeneric
11/2019
1Trimethoprim (Proloprim)FDA LinkGeneric
11/2019
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
09/2009
1Transforming Growth Factor beta1 (TGF beta 1)IBA
09/2009
1alpha 1-Antitrypsin (alpha 1 Antitrypsin)IBA
09/2009
1Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
09/2009
1Glutathione Transferase (Glutathione S-Transferase)IBA
09/2009
1Epithelial Sodium ChannelsIBA
07/2009
1Amiloride (Midamor)FDA LinkGeneric
07/2009
1Keratin-8 (Keratin 8)IBA
12/2006
1Codon (Codons)IBA
06/2006

Therapy/Procedure

5Therapeutics
03/2022 - 01/2019
1Intravitreal Injections
01/2021
1High-Protein Diet
01/2020
1Secondary Prevention
01/2020
1Precision Medicine
01/2020
1Terminal Care (Care, Terminal)
01/2018
1Traction
01/2017
1Lung Transplantation
02/2016
1Organ Transplantation
02/2016